Provided by Tiger Trade Technology Pte. Ltd.

Arbutus Biopharma

5.01
-0.0600-1.18%
Volume:233.38K
Turnover:1.17M
Market Cap:986.67M
PE:6.35
High:5.05
Open:5.04
Low:4.99
Close:5.07
52wk High:5.45
52wk Low:3.50
Shares:196.94M
Float Shares:123.00M
Volume Ratio:0.30
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7896
EPS(LYR):-0.1748
ROE:89.58%
ROA:48.84%
PB:3.81
PE(LYR):-28.65

Loading ...

Arbutus Biopharma commences $230M modified Dutch Auction tender offer

TIPRANKS
·
Aug 24

Arbutus Biopharma Launches Us$230 Million Modified Dutch Auction Tender Offer at US$5 to Us$5.75 a Share

Reuters
·
Aug 24

Arbutus Commences Us$230 Million Modified “Dutch Auction” Tender Offer of Its Common Shares at a Price not Greater than Us$5.75 nor Less than Us$5.00 Per Share

THOMSON REUTERS
·
Aug 24

Arbutus Biopharma Shares Rise on $230 Million Stock Buyback

Dow Jones
·
Aug 21

Sector Update: Healthcare Stocks Edge Higher Pre-Bell Friday

MT Newswires Live
·
Aug 21

U.S. Stocks on the MOVE-Ubiquiti, BJ's Wholesale, Arbutus

Reuters
·
Aug 21

Arbutus Biopharma Announces Major Share Repurchase Tender Offer

TIPRANKS
·
Aug 21

Arbutus Climbs After Unveiling Buyback from Moderna Settlement Proceeds

Reuters
·
Aug 21

Arbutus Biopharma to repurchase $230M of shares through Dutch Auction

TIPRANKS
·
Aug 21

Arbutus Plans Modified Dutch Auction Tender Offer to Repurchase up to Us$230 Million Shares at US$5-5.75 Each

Reuters
·
Aug 21

Arbutus Biopharma Corp: Offer Purchase Price of not Less than Us$5.00 Per Share and not More than Us$5.75 Per Share, in Cash

THOMSON REUTERS
·
Aug 21

Arbutus Biopharma Corp: Offer is Expected to be Funded Through Company's Cash on Hand

THOMSON REUTERS
·
Aug 21

Arbutus Announces Intent to Repurchase up to Us$230 Million of Its Common Shares Through Modified “Dutch Auction” Tender Offer

THOMSON REUTERS
·
Aug 21

Arbutus Biopharma Corp: Offer is Expected to Commence on or About August 24, 2026 And, Unless Extended or Terminated by Co

THOMSON REUTERS
·
Aug 21

ProQR Q2 Revenue More than Doubles

Reuters
·
Aug 13

Atea Pharmaceuticals Q2 Loss Narrows as HCV Trial Expenses Decline

Reuters
·
Aug 13

Arbutus Q2 FY26 Net Loss Widens to $5.1 Million; Revenue Drops 90.56% to $1.01 Million

Reuters
·
Aug 12

Arbutus Biopharma Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.014M Beat $700.000K Estimate

Benzinga Earnings
·
Aug 12

Earnings Flash (ABUS) Arbutus Biopharma Posts Q2 Loss $0.03 a Share, vs. FactSet Est of $0.02 Loss

MT Newswires Live
·
Aug 12

Arbutus Biopharma Q2 Revenue USD 1 Million

THOMSON REUTERS
·
Aug 12